Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 401 clinical trials
Featured trial
INCB 18424-304: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE-AD2) for 304

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

atopic dermatitis
eczema
atopic dermatitis/eczema
dermatitis
  • 379 views
  • 25 Aug, 2021
  • 11 locations
Featured trial
INCB 18424-303: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE-AD1)

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

atopic dermatitis
eczema
atopic dermatitis/eczema
  • 270 views
  • 25 Aug, 2021
  • 19 locations
Featured trial
  • 1383 views
  • 08 Dec, 2020
  • 53 locations
Featured trial
We are currently recruiting participants for the BLUEPRINT study. This study investigates the effectiveness, safety, and tolerability of the drug BLU-5937 for chronic itch in people with eczema.

The BLUEPRINT study consists of taking two tablets orally, twice a day, for a period of 4 weeks. This treatment is experimental. You will have 50% chance to receive BLU-5937 and 50% chance to receive the placebo. There will be a total of 5 visits at the clinic and 2 …

eczema
adult atopic dermatitis
atopic dermatitis/eczema
dermatitis
atopic dermatitis
  • 44 views
  • 10 Dec, 2020
  • 25 locations
Featured trial
Eczema Research Study - Compensation up to $420

  If you have symptoms of eczema such as itchy red patches you may qualify for a Research Study. Qualified participants receive study-related exams, medication and care from a board-certified dermatologist at no cost.  

  • 140 views
  • 23 Nov, 2020
  • 1 location
Featured trial
  • 375 views
  • 07 Nov, 2020
  • 1 location
Featured trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis

compared to placebo in adult subjects with moderate to severe atopic dermatitis (AD). This study will also assess the safety, tolerability, and pharmacokinetics of Etokimab. The study will have a

  • 53 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

  • 468 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Study 203121: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis

Study 203121: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis

  • 438 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A phase 3 confirmatory study investigating the efficacy and safety of dupilumab monotherapy administered to adult patients with moder-to-severe atopic dermatitis

A phase 3 confirmatory study investigating the efficacy and safety of dupilumab monotherapy administered to adult patients with moder-to-severe atopic dermatitis

  • 102 views
  • 08 Nov, 2020
  • 1 location